Neuropathy: Clinical Trials

15 trials for Neuropathy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed, 4 terminated, 2 withdrawn, 1 active not recruiting. 15 Phase 2, 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 215Completed 6, Terminated 4, Withdrawn 2, Active not recruiting 1, Not yet recruiting 1, Unknown 1
Phase 12Active not recruiting 1, Completed 1

Follow Neuropathy: new trials by email Literature Review of Neuropathy trials Research Report on Neuropathy

Trials (filtered) newest first · largest first

All 15 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
NeuroGuard: Psilocybin Trial for Preventing Chemo-induced Neuropathy
Psilocybin (drug), Standard of Care (SOC) - Psilocybin, Neuropathy
Phase 2Not yet recruitingM.D. Anderson Cancer Center832026-11-042026-10-05
SPI-1005 for Prevention and Treatment of Chemotherapy Induced Hearing Loss
SPI-1005 Low Dose, SPI-1005 Middle Dose, SPI-1005 High Dose - Lung Cancer, Head and Neck Cancer
Phase 2WithdrawnSound Pharmaceuticals, Incorporated2026-06-012026-06-03
BXQ-350 in Newly Diagnosed Metastatic Colorectal Carcinoma
BXQ-350, Placebo - Metastatic Colorectal Carcinoma, Neuropathy
Phase 1 / Phase 2Active not recruitingBexion Pharmaceuticals, Inc.1952023-01-092026-09-29
Study of Nicotine for Pain Associated With Chemotherapy-Induced Peripheral Neuropathy
Nicotine Transdermal Patch - Neuropathy, Peripheral Neuropathy
Phase 2TerminatedVirginia Commonwealth University42020-07-312023-11-08
The Effect of Lacosamide in Peripheral Neuropathic Pain
Lacosamide, Placebo - Neuropathic Pain, Neuropathy;Peripheral
Phase 2TerminatedDanish Pain Research Center632019-01-152023-02-16
The Efficacy and Safety of Clonidine Hydrochloride Topical Gel, vs Clonidine Hydrochloride Gel Comparator to Treat Painful Diabetic Neuropathy
Clonidine Hydrochloride Topical Gel, 0.1%, Clonidine Hydrochloride Gel Comparator - Painful Diabetic Neuropathy, Diabetic Neuropathy
Phase 2CompletedBioDelivery Sciences International1382015-12-012017-09-20
Study of Clonidine Hydrochloride Topical Gel, 0.1% in the Treatment of Pain Associated With Diabetic Neuropathy
Clonidine Gel 0.1%, Placebo - Painful Diabetic Neuropathy, Diabetic Neuropathy
Phase 2CompletedBioDelivery Sciences International2602014-03-012017-09-26
Topical Menthol for the Treatment of Chemotherapy Induced Peripheral Neuropathy
topical menthol, placebo lotion - Breast Cancer, Colon Cancer
Phase 2TerminatedColumbia University122013-08-012024-07-11
The Arterial Measurement of the Blood Flow Volume After Iloprost Stimulation
Ilomedin - Diabetes, Arteriosclerosis
Phase 2UnknownPrim PD Dr Afshin Assadian1002012-10-012018-10-17
Eribulin in Combination With Cyclophosphamide in Patients With Solid Tumor Malignancies
Eribulin, Cyclophosphamide - Malignant Solid Tumour, Breast Cancer Nos Metastatic Recurrent
Phase 1 / Phase 2CompletedUniversity of California, San Francisco442012-03-272021-02-03
Therapeutic Interventions For Pain Induced By Vincristine Treatment For Childhood Acute Lymphoblastic Leukemia (ALL)
gabapentin, placebo - Acute Lymphoblastic Leukemia, Neuropathy
Phase 2CompletedSt. Jude Children's Research Hospital512012-01-242019-06-19
Safety and Preliminary Evidence of Efficacy of Escalating Doses of Dimiracetam in AIDS Patients With Painful Neuropathy
dimiracetam, sugar pill - Neuropathy, AIDS
Phase 2CompletedNeurotune AG1162009-10-012010-06-02
Study of Lenalidomide as a Treatment for Neuropathy Associated With Monoclonal Gammopathy of Undetermined Significance
Lenalidomide - Neuropathy, Nonmalignant Monoclonal Gammopathy of Undetermined Significance (MGUS)
Phase 2TerminatedDartmouth-Hitchcock Medical Center82008-04-012018-09-11
Epoetin Alfa for HIV-Associated Neuropathy Trial
epoetin alfa - HIV Infections, Neuropathy
Phase 2WithdrawnWashington University School of Medicine2007-11-012011-08-09
A Comparison of EpiCeptâ„¢ NP-1 Topical Cream vs. Oral Gabapentin in Postherpetic Neuralgia (PHN)
EpiCept-NP-1 Cream, Gabapentin Capsules, placebo - Post Herpetic Neuralgia, PHN
Phase 2CompletedEpiCept Corporation3602007-07-012011-07-27

Narrower conditions

Neuralgia (5)  ·  Diabetes Mellitus (3)  ·  Diabetic Neuropathies (3)  ·  Acquired Immunodeficiency Syndrome (2)  ·  Breast Neoplasms (2)  ·  Pain (2)  ·  Arteriosclerosis (1)  ·  Carcinoma (1)  ·  Colonic Neoplasms (1)  ·  Colorectal Neoplasms (1)  ·  Deafness (1)  ·  HIV Infections (1)  ·  Head and Neck Neoplasms (1)  ·  Hearing Loss (1)  ·  Lung Neoplasms (1)

Broader conditions

Nervous System Diseases (8)  ·  Neurologic Manifestations (8)  ·  Pathological Conditions, Signs and Symptoms (8)  ·  Signs and Symptoms (8)  ·  Neuromuscular Diseases (7)  ·  Peripheral Nervous System Diseases (6)  ·  Neoplasms (5)  ·  Pain (5)  ·  Endocrine System Diseases (4)  ·  Neoplasms by Site (4)  ·  Diabetes Complications (3)  ·  Glucose Metabolism Disorders (3)  ·  Immune System Diseases (3)  ·  Metabolic Diseases (3)  ·  Nutritional and Metabolic Diseases (3)

Interventions

Gabapentin (2)  ·  Cyclophosphamide (1)  ·  Epoetin Alfa (1)  ·  Erythropoietin (1)  ·  Injections (1)  ·  Lacosamide (1)  ·  Lenalidomide (1)  ·  Menthol (1)  ·  Pharmaceutical Preparations (1)  ·  Psilocybin (1)  ·  Solvents (1)  ·  Standard of Care (1)  ·  Sugars (1)  ·  Tobacco Use Cessation Devices (1)  ·  dimiracetam (1)

Sponsors

BioDelivery Sciences International (2)  ·  Bexion Pharmaceuticals, Inc. (1)  ·  Columbia University (1)  ·  Danish Pain Research Center (1)  ·  Dartmouth-Hitchcock Medical Center (1)  ·  EpiCept Corporation (1)  ·  M.D. Anderson Cancer Center (1)  ·  Neurotune AG (1)  ·  Prim PD Dr Afshin Assadian (1)  ·  Sound Pharmaceuticals, Incorporated (1)  ·  St. Jude Children's Research Hospital (1)  ·  University of California, San Francisco (1)  ·  Virginia Commonwealth University (1)  ·  Washington University School of Medicine (1)

Countries

United States (10)  ·  Austria (1)  ·  Denmark (1)  ·  India (1)  ·  South Africa (1)

Top investigators

Aziz Shaibani, MD (2)  ·  Afshin Assadian, Prim PD Dr (1)  ·  Bruce Cohen, MD (1)  ·  Daniel R Malan, MD (1)  ·  David B. Clifford, MD (1)  ·  David Simpson, MD (1)  ·  Dawn Hershman, MD (1)  ·  Doralina Anghelescu, MD (1)  ·  Elijah W. Stommel, MD, PhD (1)  ·  Hope S Rugo, MD (1)  ·  Jonathan Kil, MD (1)  ·  Justin McArthur, MBBS, MPH (1)  ·  Moran Amit, MD (1)  ·  Nanna B Finnerup, Professor (1)

Results publications

PMID 31604475, PMID 35587172, PMID 37815684

NIH funding

2018 (1), U01NS032228 (1)